Mouse Anti-BCL9L Recombinant Antibody (CBT3990) (V2LY-0625-LY807)

Wang, X., Feng, M., Xiao, T., Guo, B., Liu, D., Liu, C., ... & Zhu, D. (2021). BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer. Oncogene, 40(16), 2982-2997.

Lu, M., Qin, X., Zhou, Y., Li, G., Liu, Z., Geng, X., & Yue, H. (2021). Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis. Cell death & disease, 12(1), 1-17.

Yang, M., Wei, Z., Feng, M., Zhu, Y., Chen, Y., & Zhu, D. (2021). Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer. Frontiers in oncology, 11.

Huge, N., Sandbothe, M., Schröder, A. K., Stalke, A., Eilers, M., Schäffer, V., ... & Skawran, B. (2020). Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma. Hepatology international, 14(3), 373-384.

Zhang, S., Chen, H., Liu, W., Fang, L., Qian, Z., Kong, R., ... & Cao, X. (2020). miR-766-3p targeting BCL9L suppressed tumorigenesis, epithelial-mesenchymal transition, and metastasis through the β-catenin signaling pathway in osteosarcoma cells. Frontiers in cell and developmental biology, 8, 1086.

Moghe, A., & Monga, S. P. (2020). BCL9/BCL9L in hepatocellular carcinoma: will it or Wnt it be the next therapeutic target?.

Gay, D. M., Ridgway, R. A., Müller, M., Hodder, M. C., Hedley, A., Clark, W., ... & Sansom, O. J. (2019). Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer. Nature communications, 10(1), 1-16.

Sun, R., Liu, Z., Han, L., Yang, Y., Wu, F., Jiang, Q., ... & Huang, C. (2019). miR‐22 and miR‐214 targeting BCL9L inhibit proliferation, metastasis, and epithelial‐mesenchymal transition by down‐regulating Wnt signaling in colon cancer. The FASEB Journal, 33(4), 5411-5424.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols